Blue Trust Inc’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-306
Closed -$12.4K 3031
2024
Q3
$12.4K Buy
306
+106
+53% +$5.21K ﹤0.01% 2114
2024
Q2
$8.4K Buy
+200
New +$7.93K ﹤0.01% 1997
2024
Q1
Sell
-82
Closed -$3K 2755
2023
Q4
$3K Sell
82
-147
-64% -$4.89K ﹤0.01% 2067
2023
Q3
$7K Buy
+229
New +$7.9K ﹤0.01% 1560
2023
Q1
Sell
-13
Closed -$1K 2678
2022
Q4
$1K Buy
+13
New +$418 ﹤0.01% 2168

Other funds holding ASTH

Blue Trust Inc's ASTH Position: Q4 2024 in Review

Blue Trust Inc sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 306 shares — an estimated $12.4K sold.

Blue Trust Inc first reported a position in ASTH in Q4 2022 and held it in 5 quarters. The position peaked at $12.4K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Blue Trust Inc reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 306 Astrana Health shares in Q4 2024, an estimated $12.4K.
  • Blue Trust Inc first reported a position in Astrana Health in Q4 2022 and held it in 5 quarters.
  • Blue Trust Inc's Astrana Health position peaked at $12.4K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.